Stay Tuned for the 2026 Agenda!
2025 Agenda
We’re building a high-impact experience packed with the insights, strategies, and connections that matter most to the PSP community. This year’s program will feature a dynamic blend of expert-led keynotes, deep-dive panels, interactive roundtables, and real-world case studies—all focused on the most urgent and emerging challenges in Patient Support Programs. From digital transformation and evolving reimbursement models to operational best practices and data-driven innovation, you’ll leave equipped to lead in a changing landscape.
Day 1
Breakfast & Registration
Welcome and Open Day 1
Ian McQueen, Partner - MATRIX
Resilience, Change, and the Future of Patient Support
Jay is the world’s leading expert on change fluency and a renowned keynote speaker with over 13 years experience in strategy and human capital. Jay brings a rare depth of perspective to his work. As a half-blind cancer survivor, Jay has turned adversity into a story of strength and impact. In this powerful keynote, Jay will inspire you to see disruption not as a barrier but as a catalyst for innovation. His journey of resilience will ignite fresh perspectives on how Patient Support Programs can evolve with clarity, confidence, and purpose to better serve patients in an ever-changing healthcare landscape.
Jay Kiew, Innovation and Change Navigation Strategist - The Change Fluency™ Co.
Navigating Change: The Evolution of Drug Development and Patient-Centered Care
As the pharmaceutical landscape evolves, organizations are adapting to the shifting dynamics of drug development—particularly in chronic and specialty products. This session will explore the implications of emerging pipeline trends, the increasing complexity of patient journeys, and the transformation of healthcare delivery models. Attendees will gain insights into how these forces intersect to impact product support strategies, operational readiness, and market access planning.
Mark Omoto, GM, Thought Leadership, Marketing and Communications - IQVIA
BREAK
Provider Panel: Today's Critical Issues
This panel will provide a range of perspectives from senior leaders at leading Providers. The conversation will focus on navigating the critical issues facing PSPs today. The panel will explore key trends with the goal of providing practical insights and actionable ideas.
Kiran Patel, Sr. Manager, Patient Support Strategy - AstraZeneca
Matt Simioni, Sr. Dir., Strategic Partnerships & Business Development - Shoppers DrugMart Specialty Health Network
Jessica Lovett, VP, Commercial Strategy and Innovation - Innomar / Cencora
Sameen Rehman, VP Product Innovation and Analytics, Specialty Health - McKesson Specialty Health
Digitally Powered PSPs: A Patient Experience Reimagined – Game Show Edition
Specialty therapies are more complex than ever, and traditional patient support programs (PSPs) can’t keep pace. This session explores how digital innovation, AI-driven insights and decentralized care are transforming PSPs—offering patients greater choice, faster access, and more personalized support.
Michael Duong, Head of Innovation - Roche
Lori Singh, VP, Pharma Solutions & Digital Health - Calian
Tazmin Leipsig, Dir. of Digital Health - Calian
LUNCH
PSPs as a Strategic Enabler for Customer Experience - A General Manager's Perspective
Hear from a GM’s perspective on the current opportunities and challenges facing PSPs in Canada. Explore the potential for PSPs to be a key strategic enabler for customer experience. Learn how collaboration across the industry can build sustainable programs and create impactful results, while effectively engaging global stakeholders.
Rami Fayed, VP and General Manager - Abbvie
Dominique Perron, AbbVie Care Head, Patient Experience - Abbvie
From Burden-Shifting to Collaboration: How Manufacturers Can Redefine Digital PSPs
The future of digital PSPs isn’t about choosing a single vendor solution—it’s about creating interoperable, agnostic systems that connect every point of collaboration. This session will unpack how technology and process re-engineering together can break the cycle of burden-shifting between stakeholders. Using compassionate access and oncology as a lens, we’ll highlight the importance of inclusive workflows, exception management, and back-office visibility. Attendees will learn how to design PSPs that are adaptable, collaborative, and ready for the next generation of specialty launches.
Julie Tremblay-Roy, Dir. of Growth - Auxita
Shelley Burnett, President - Auxita
From Idea to Investment: Presenting PSP Initiatives that Win Leadership Support
Practical strategies to successfully present new initiatives to senior leadership – best practice quick fire session
Nicole Serena, CEO - PSP Solutions
BREAK
Adding Private Payer Advocacy to the PSP Toolkit
Advocating to private payers requires different strategies than those used for public payers. This session will explore how patient support programs can play a critical role in patients private payer advocacy, and how having the right strategy and approach can increase the chances of success.
Suzanne Lepage, Private Health Plan Strategist - SL Consulting
Looking Ahead: External Perspectives on the Future of PSPs
External experts from diverse areas share their perspectives on the opportunities and challenges shaping Patient Support Programs. They’ll discuss how PSPs could evolve to deliver greater value for patients and driving positive impact across the healthcare system.
Dr. Quinn Grundy, Associate Professor - University of Toronto
Lisa Machado, Executive Director & Healthcare Systems Consultant - Canadian CML Network
Sandra Hanna, CEO - Neighbourhood Pharmacy Association of Canada
Leader Panel: Demonstrating and Communicating the Value of PSPs to Your Organization
Patient Support Programs (PSPs) are essential to the Canadian market, yet they are often misunderstood within organizations and can be seen primarily as cost drivers. When sustainability is discussed, the conversation too often centers on cost reduction alone. This panel is about reframing that discussion. Sustainability must also mean value generation — improved adherence, better patient outcomes, and uniquely Canadian real-world data that informs both affiliates and global decision-making. The goal is to help attendees understand how PSP leaders can effectively demonstrate and communicate this value of PSPs to internal and external stakeholders.
Phil Peters, Consultant
Morgan McNaughton, Patient Experience Lead - UCB
Stephanie Babbitt, Lead, Patient Support Services - Sanofi
Steve Browne, Associate Dir., Patient Support Program Lead - Lilly
Insight Exchange: Your Key Takeaways
End the day by connecting, reflecting, and sharing your biggest insights. This interactive wrap-up invites participants to exchange key takeaways, uncover common themes, and spark fresh ideas to carry forward beyond the Summit.
Open Forum with All Attendees
CLOSE
Ian McQueen, Partner - MATRIX
Networking Reception
End of Day 1
Workshops, Leadership Round Table and Networking Meet and Greet
If you have preliminary interest in any of these sessions, please complete the following form and we will send you more details.
Day 2
Breakfast & Registration
Welcome and Open Day 2
Ian McQueen, Partner - MATRIX
What to do as the PSP bubble bursts?
As the PSP ecosystem rapidly evolves due market pressures, the model of the past is changing and those who don’t adapt risk being left behind. This session will explore key trends that are driving change in the PSP landscape.
Dan Zimskind, Manager at ZS, Learning Health Systems - ZS
Steve Browne, Associate Dir., Patient Support Program Lead - Lilly
Matt Simioni, Senior Director, Strategic Pharmaceutical Partnerships & Business Development - Shoppers Drug Mart Specialty Health Network
Using Data to Measure the Impact of Patient Support Programs
Many PSP managers struggle to clearly demonstrate the value of their programs to senior management. To support them, we need to identify evidence that shows PSPs generate a measurable return on investment. While PSPs are not designed—or permitted—to be positioned as sales drivers, they can have a direct impact on the number of patients who initiate therapy and how long they remain on it, which ultimately influences brand performance.
- What data exists (Canadian or international) that demonstrates this link?
- What does the literature say about incremental outcomes when a PSP is in place versus when it is not?
- Are there credible benchmarks or case studies that show the magnitude of this effect?
- What is the evidence base that connects PSPs to improved patient persistence and adherence, and therefore to a tangible return?
Calum Neish, Senior Principal - IQVIA
Legal and Policy Updates: What They Mean for PSPs
This session will provide an update on potential policy and legal developments that could have implications for patient support programs.
- Enhancing the patient experience with technology and managing the privacy implications that arise
- Summary of recent developments related to patient choice of pharmacy rules
- Reviewing ongoing policy initiatives around Canadians’ access to care and role of PSPs
Manpreet Singh, Partner - Norton Rose Fulbright
BREAK
Balancing Acts: Navigating Cost and Care for PSP sustainability
Having sat on both sides of the table, this panel of industry leaders brings a unique perspective to one of the toughest challenges in Patient Support Programs (PSPs): achieving long-term sustainability. Drawing on their experience as former manufacturers and current PSP providers, the panelists will explore how cost pressures, operational realities, and collaboration dynamics look from both viewpoints and what it really takes to find balance. You’ll walk away with:
- A clear view of the day-to-day operational and administrative realities of delivering PSPs
- Insight into the financial and organizational pressures manufacturers face to balance quality with cost
- Practical ideas and real-world examples of how providers and manufacturers can collaborate to build more efficient, sustainable, and patient-focused programs
Sangeeta Shah, Dir., Operational Excellence – Patient Services - Takeda
Shyam Miani, Founder and President - PSPSync
Virginie Leduc, Dir., Patient Programs - NavieGo - Bioscript Solutions
Bev Herzegh, Co-founder - Sentrex
Measuring What Matters: Scorecards, Financial Health & the Future of PSPs - PSP Connections Working Group
An expert panel discussion with members of the PSP Connections™ Industry Working Group, sharing progress on new tools and standards that support stronger financial oversight, provider performance scorecards, and audit-ready programs. Learn how these industry-led initiatives are setting a new level for PSP excellence.
Éric Lefrançois, Head of Patient Support Services - Sanofi
Michelle Capon, Dir. Patient Support Programs & Customer Service - GSK
Julien Chaumillon, PSP Manager - Oncology - Pfizer
Driving External and Cross-Functional Collaboration in PSP Innovation
Our session will explore the transformative potential of external and cross-functional collaboration in Patient Support Programs (PSPs) and PSP technology innovation. We will aim to unpack the “why,” “when,” and “how” of collaboration, offering a roadmap for success and showcasing real-world examples of strategic partnerships that have delivered measurable impact.
Kimberley Cody, Dir. of Offerings and Marketing- STI
Ramy el Kholi, Chief Commercial Officer - OkRx
Allison Weir, Associate Dir., Patient Support Services- Gilead
Tim Rice, CEO - The Rounds
LUNCH
Revisiting PSP Data: From Insight to Impact
PAAB’s 2024 Real-World Evidence update cracked open new possibilities for PSP data—but many opportunities remain untapped. This session explores how PSP insights can spark action: uncovering trends, understanding patient journeys, and shaping smarter, compliant communications that drive both internal strategy and external impact.
Amy Moriarty, SVP, Managing Director - the adpharm
Hitesh Patel, Head, Patient Support Services - Sanofi
What can AI Really Do? Ask a CTO!
AI keeps getting pitched as the silver bullet for PSPs. Some of it is hope, some is hype, and some is already here. In this candid Q&A, Ellen Campana, PhD, CTO and co-founder of Compose Health, breaks down what modern AI actually can do inside regulated pharma workflows and what it cannot. Drawing on two decades building production AI and recent work deploying agent-based systems inside top biopharma teams, Ellen will separate marketing claims from operational reality, show where AI creates measurable lift, and where human expertise remains critical.
Ellen Campana, Co-Founder, Chief Technology Officer - Compose Health Inc.
Angelina Brathwaite, Director Life Sciences, Brunel and Director at Women Leaders in Pharma
Collaboration Roundtables
Join your colleagues for interactive roundtable discussions to delve deeper into the Summit’s insights.
Open Forum with All Attendees
BREAK
Leader Panel: Progressing PSPs - Where Do We Go From Here?
PSP Leaders will discuss the Summit’s core themes and roundtable findings, and identify opportunities to progress PSPs as an industry
Shaminder Singh, Dir., Business Development - Bayshore Specialty Health
Ryan Macri, Dir. Value & Access, Patient Services - Amgen
Daiana Matarazzo, Head of Patient Services - Takeda
Alain Boutin, Head of Patient Services - EMD
CLOSE
Ian McQueen, Partner - MATRIX
Adjourn
Workshops, Leadership Round Table and Networking Meet and Greet
If you have preliminary interest in any of these sessions, please complete the following form and we will send you more details.